Suchergebnisse - "Cao, Danni"

PubPharm (11)

1

NCP, a dual kappa and mu opioid receptor agonist, is a potent analgesic against inflammatory pain without reinforcing or aversive properties

enthalten in: The Journal of pharmacology and experimental therapeutics | 2024

von Huang, P. | Ho, C. | Cao, D. | +11

2

Maternal anemia is associated with adverse maternal and neonatal outcomes in Mbarara, Uganda

enthalten in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians | 2023

von Edelson, P. | Cao, D. | James, K. | +4

3

Preclinical Studies on Nalfurafine (TRK-820), a Clinically Used KOR Agonist

enthalten in: Handbook of experimental pharmacology | 2022

von Zhou, Y. | Freeman, K. | Setola, V. | +4

4

Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects

enthalten in: Neuropharmacology | 2022

von Huang, P. | Chen, C. | Cao, D. | +2

5

Quantification of the impact of traffic incidents on speed reduction : A causal inference based approach

enthalten in: Accident; analysis and prevention | 2021

von Cao, D. | Wu, J. | Dong, X. | +3

6

Verifying the role of 3-hydroxy of 17-cyclopropylmethyl-4,5α-epoxy-3,14β-dihydroxy-6β-[(4'-pyridyl) carboxamido]morphinan derivatives via their binding affinity and selectivity profiles on opioid receptors

enthalten in: Bioorganic chemistry | 2021

von Huang, B. | Gunta, R. | Wang, H. | +9

7

Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators

enthalten in: Future medicinal chemistry | 2021

von Wang, H. | Cao, D. | Gillespie, J. | +4

8

Exploring the putative mechanism of allosteric modulations by mixed-action kappa/mu opioid receptor bitopic modulators

enthalten in: Future medicinal chemistry | 2021

von Wang, H. | Cao, D. | Gillespie, J. | +4

9

Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue : Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological Effects

enthalten in: ACS chemical neuroscience | 2020

von Cao, D. | Huang, P. | Chiu, Y. | +7

10

C-Phycocyanin inhibits hepatic gluconeogenesis and increases glycogen synthesis via activating Akt and AMPK in insulin resistance hepatocytes

enthalten in: Food & function | 2018

von Ren, Z. | Xie, Z. | Cao, D. | +4